InsiderTrades

Form 4 for SHC Sotera Health Co

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0000950170-24-026450 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-03-05 2024-03-04 SHC Rutz Michael P Pres of Sterigenics A - Grant $0.00 +34.3K 627.5K +6% $0
DM 2024-03-05 2024-03-02 SHC Rutz Michael P Pres of Sterigenics F - Tax $14.56 -5,501 596.3K -0.9% -$80.1K
D 2024-03-05 2024-03-04 SHC Rutz Michael P Pres of Sterigenics S - Sale $14.31 -83.1K 544.4K -13% -$1.19M
D 2024-03-05 2024-03-04 SHC Rutz Michael P Pres of Sterigenics A - Grant $0.00 +68.1K 68.1K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.01 par value per share ("Common Stock") 2024-03-04 A A 34,270 $0.00 627,518 D — — (F3) These securities consist of RSUs that were granted on March 4, 2024, pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs vest annually in three equal installments commencing March 2, 2025.
2 Common Common Stock, $0.01 par value per share ("Common Stock") 2024-03-02 F D 3,063 $14.56 593,248 D — — (F2) These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 9,475 RSUs, which represents 33% of the RSU award granted to the Reporting Person on March 6, 2023. This award was granted pursuant to the terms of an RSU agreement under the 2020 Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.
3 Common Common Stock, $0.01 par value per share ("Common Stock") 2024-03-02 F D 2,438 $14.56 596,311 D — — (F1) These securities represent the number of shares of Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations due upon the vesting of 8,320 Restricted Stock Units ("RSUs"), which represents 33% of the RSU award granted to the Reporting Person on March 2, 2022. This award was granted pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan ("2020 Incentive Plan"). Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions.
4 Common Common Stock, $0.01 par value per share ("Common Stock") 2024-03-04 S D 83,109 $14.31 544,409 D — — (F4) On March 4, 2024, the Reporting Person sold a total of 83,109 shares of Common Stock of the Issuer in an underwritten public secondary offering (the "Offering"). (F5) Reflects a price equal to the Offering price per share less underwriting discounts and commissions payable thereon, as disclosed in the Issuer's Prospectus 424(b)(7), filed with the United States Securities and Exchange Commission on February 29, 2024. (F6) These securities consist of 68,063 RSUs and 476,346 shares of Common Stock. 339,030 of the shares of Common Stock are vested, and 137,316 shares of Common Stock remain subject to vesting conditions. Shares of unvested Common Stock will vest on a daily basis, pro rata through May 13, 2025 (the five year anniversary of the date of grant).
5 Derivative Stock Options 2024-03-04 A A 68,063 $0.00 68,063 D $14.59 · — to 2034-03-04 68,063 Common Stock (F7) These options were granted on March 4, 2024, pursuant to the terms of a stock option agreement under the 2020 Incentive Plan. The options vest annually in three equal installments commencing March 2, 2025, subject to vesting conditions.